{Reference Type}: Case Reports
{Title}: Managing Acute Intermediate Risk Pulmonary Thromboembolism in a Patient Who Developed Heparin-Induced Thrombocytopenia: Review of Current Guidelines and Literature.
{Author}: Asllanaj B;Benge E;Bhatia S;McWhorter Y;
{Journal}: J Investig Med High Impact Case Rep
{Volume}: 11
{Issue}: 0
{Year}: Jan-Dec 2023
暂无{DOI}: 10.1177/23247096231166673
{Abstract}: Intermediate-risk pulmonary embolism describes hemodynamically stable patients with evidence of right ventricular strain, whereas high-risk pulmonary embolism comprises hemodynamic decompensation resulting in cardiogenic shock. The clinical manifestations of the two aforementioned conditions are challenging to treat in the setting of heparin-induced thrombocytopenia (HIT). Without immediate therapeutic anticoagulation, patients can subsequently deteriorate and require additional advanced therapies, with the end-goal of restoring pulmonary artery perfusion. We present the case of a male with bilateral intermediate-risk pulmonary emboli who developed type 2 HIT prompting different selection of appropriate management strategies.